« U.S. Attorney News Release: Stryker Biotech and Its Top Management | Main | FDA Publishes Guidance on Diagnostic Tests for 2009 H1N1 Influenza »

FDA: Byetta Label Revised to Include Safety Information on Possible


FDA: Byetta Label Revised to Include Safety Information on Possible Kidney Problems
The U.S. Food and Drug Administration today acted on new safety information about possible kidney function problems, including kidney failure, in patients taking Byetta (exenatide), a drug used to treat Type 2 diabetes.
 

©2006 FDA-News.com. All rights reserved.